Handelsbanken Fonder Ab Ironwood Pharmaceuticals Inc Transaction History

Handelsbanken Fonder Ab

  • $26.2 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024
BUY
$3.93 - $7.04 $45,588 - $81,664
11,600 Added 24.24%
59,455 $245,000
Q4 2023

Feb 01, 2024
BUY
$8.79 - $11.51 $166,130 - $217,539
18,900 Added 65.27%
47,855 $547,000
Q2 2021

Aug 03, 2021
BUY
$10.16 - $13.11 $19,304 - $24,909
1,900 Added 7.02%
28,955 $373,000
Q2 2020

Aug 13, 2020
BUY
$9.14 - $11.97 $247,282 - $323,848
27,055 New
27,055 $279,000

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $271M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email